{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:13:37Z","timestamp":1788178417946,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.oftale.2026.502655","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T15:20:14Z","timestamp":1787412014000},"page":"502655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurovascular unit-targeted therapeutic strategies in diabetic retinopathy"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-6270","authenticated-orcid":false,"given":"S.","family":"Fragiotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ciancimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0744-0722","authenticated-orcid":false,"given":"G.","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","article-title":"Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives","volume":"25","author":"Sim\u00f3","year":"2014","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.oftale.2026.502655_bib0010","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bjophthalmol-2012-302005","article-title":"Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications","volume":"96","author":"Sim\u00f3","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.oftale.2026.502655_bib0015","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/pharmaceutics13081320","article-title":"Neurovascular unit: a new target for treating early stages of diabetic retinopathy","volume":"13","author":"Simo","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.oftale.2026.502655_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/0394632017748841","article-title":"Ultrastructure of neurovascular changes in human diabetic retinopathy","volume":"31","author":"Feher","year":"2018","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0025","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin","volume":"102","author":"Barber","year":"1998","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.oftale.2026.502655_bib0030","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.oftale.2026.502655_bib0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.visres.2010.08.024","article-title":"Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy","volume":"51","author":"van Dijk","year":"2011","journal-title":"Vision Res"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3390\/nu14040792","article-title":"Understanding neurodegeneration from a clinical and therapeutic perspective in early diabetic retinopathy","volume":"14","author":"Fragiotta","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.oftale.2026.502655_bib0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.76.8.461","article-title":"Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas","volume":"76","author":"Hardy","year":"1992","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0050","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1038\/s41598-025-89734-2","article-title":"Early detection of retinal dysfunction in type 1 diabetes without retinopathy using multifocal electroretinography","volume":"15","author":"Arias-Alvarez","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12886-024-03335-7","article-title":"Abnormalities of retinal function in type 2 diabetes mellitus patients without clinical diabetic retinopathy detected by multifocal electroretinogram","volume":"24","author":"Li","year":"2024","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.oftale.2026.502655_bib0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10633-023-09943-w","article-title":"Foveal avascular zone size and mfERG metrics in diabetes and prediabetes: a pilot study of the relationship between structure and function","volume":"147","author":"Zagst","year":"2023","journal-title":"Doc Ophthalmol"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0065","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1167\/iovs.07-1157","article-title":"Local diabetic retinopathy prediction by multifocal ERG delays over 3 years","volume":"49","author":"Ng","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.oftale.2026.502655_bib0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.preteyeres.2006.07.001","article-title":"A multifocal electroretinogram model predicting the development of diabetic retinopathy","volume":"25","author":"Bearse","year":"2006","journal-title":"Prog Retin Eye Res"},{"issue":"19","key":"10.1016\/j.oftale.2026.502655_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11195824","article-title":"Differences in multifocal electroretinogram study in two populations of type 1 and type 2 diabetes mellitus patients without diabetic retinopathy","volume":"11","author":"Romero-Aroca","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0080","doi-asserted-by":"crossref","first-page":"11422","DOI":"10.1038\/s41598-022-15425-x","article-title":"Early retinal functional alteration in relation to diabetes duration in patients with type 2 diabetes without diabetic retinopathy","volume":"12","author":"Srinivasan","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.oftale.2026.502655_bib0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00592-023-02076-1","article-title":"Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study","volume":"60","author":"Hern\u00e1ndez","year":"2023","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0090","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/1120672120920537","article-title":"Benefits of micronutrient supplementation for reducing the risk of wet age-related macular disease and diabetic retinopathy: an update","volume":"30","author":"Battaglia Parodi","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"13","key":"10.1016\/j.oftale.2026.502655_bib0095","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oftale.2026.502655_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110656","article-title":"Dysfunction of the neurovascular unit in diabetes-related neurodegeneration","volume":"131","author":"Yan","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"26","key":"10.1016\/j.oftale.2026.502655_bib0105","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.2174\/09298673113209990027","article-title":"Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications","volume":"20","author":"Stem","year":"2013","journal-title":"Curr Med Chem"},{"issue":"9","key":"10.1016\/j.oftale.2026.502655_bib0110","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s00125-018-4692-1","article-title":"Neurodegeneration in diabetic retinopathy: does it really matter?","volume":"61","author":"Simo","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.oftale.2026.502655_bib0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00125-017-4435-8","article-title":"Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond","volume":"61","author":"Hammes","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.oftale.2026.502655_bib0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.963615","article-title":"The pathophysiological mechanisms underlying diabetic retinopathy","volume":"10","author":"Wei","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.oftale.2026.502655_bib0125","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3390\/ijms24032927","article-title":"Advanced glycation end-products and diabetic neuropathy of the retina","volume":"24","author":"Oshitari","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.oftale.2026.502655_bib0130","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4103\/1673-5374.322457","article-title":"Diabetic retinopathy: neurovascular disease requiring neuroprotective and regenerative therapies","volume":"17","author":"Oshitari","year":"2022","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.oftale.2026.502655_bib0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.visres.2017.03.013","article-title":"M\u00fcller cells and diabetic retinopathy","volume":"139","author":"Coughlin","year":"2017","journal-title":"Vision Res"},{"issue":"9","key":"10.1016\/j.oftale.2026.502655_bib0145","first-page":"3109","article-title":"Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells","volume":"43","author":"Li","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"51","key":"10.1016\/j.oftale.2026.502655_bib0150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112561118","article-title":"Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic retinopathy","volume":"118","author":"Mills","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/ceo.14190","article-title":"Anomalies in neurovascular coupling during early diabetes: a review","volume":"51","author":"Fletcher","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502655_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101349","article-title":"Microglial regulation of the retinal vasculature in health and during the pathology associated with diabetes","volume":"106","author":"Jobling","year":"2025","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oftale.2026.502655_bib0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05660-z","article-title":"RIP3-mediated microglial necroptosis promotes neuroinflammation and neurodegeneration in the early stages of diabetic retinopathy","volume":"14","author":"Huang","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.oftale.2026.502655_bib0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12974-024-03190-9","article-title":"Suppression of inner blood-retinal barrier breakdown and pathogenic M\u00fcller glia activation in ischemia retinopathy by myeloid cell depletion","volume":"21","author":"Zhou","year":"2024","journal-title":"J Neuroinflammat"},{"key":"10.1016\/j.oftale.2026.502655_bib0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.freeradbiomed.2025.03.050","article-title":"Nitric oxide mediates negative feedback on the TXNIP\/NLRP3 inflammasome pathway to prevent retinal neurovascular unit dysfunction in early diabetic retinopathy","author":"Yang","year":"2025","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40662-021-00239-1","article-title":"Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets","volume":"8","author":"Nian","year":"2021","journal-title":"Eye Vis (Lond)"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0185","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.oftale.2026.502655_bib0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000081203","article-title":"Pathomechanisms of cystoid macular edema","volume":"36","author":"Bringmann","year":"2004","journal-title":"Ophthalmic Res"},{"issue":"2","key":"10.1016\/j.oftale.2026.502655_bib0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00417-019-04521-w","article-title":"The role of Muller cell glucocorticoid signaling in diabetic retinopathy","volume":"258","author":"Ghaseminejad","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","article-title":"Current understanding of the molecular and cellular pathology of diabetic retinopathy","volume":"17","author":"Antonetti","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"16","key":"10.1016\/j.oftale.2026.502655_bib0205","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1097\/00001756-200011090-00026","article-title":"VEGF release by retinal glia depends on both oxygen and glucose supply","volume":"11","author":"Eichler","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.oftale.2026.502655_bib0210","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050174","article-title":"IL-33 regulates M\u00fcller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy","volume":"16","author":"Augustine","year":"2023","journal-title":"Dis Models Mech"},{"key":"10.1016\/j.oftale.2026.502655_bib0215","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/jcm10030458","article-title":"Retinal vascular endothelial cell dysfunction and neuroretinal degeneration in diabetic patients","volume":"10","author":"Mrugacz","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.oftale.2026.502655_bib0220","article-title":"Hyperglycemia-regulated tRNA-derived fragment tRF-3001a propels neurovascular dysfunction in diabetic mice","volume":"4","author":"Zhu","year":"2023","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/ijerph19010439","article-title":"Neurovascular impairment and therapeutic strategies in diabetic retinopathy","volume":"19","author":"Oshitari","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.oftale.2026.502655_bib0230","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1167\/iovs.10-6293","article-title":"The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy","volume":"52","author":"Barber","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oftale.2026.502655_bib0235","doi-asserted-by":"crossref","DOI":"10.3390\/nu14040792","article-title":"Understanding neurodegeneration from a clinical and therapeutic perspective in early diabetic retinopathy","volume":"14","author":"Fragiotta","year":"2022","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.oftale.2026.502655_bib0240","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/IAE.0000000000003145","article-title":"Optical coherence tomography angiography assessment of the diabetic macula: a comparison study among different algorithms","volume":"41","author":"Borrelli","year":"2021","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.oftale.2026.502655_bib0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/iovs.64.5.23","article-title":"Progression biomarkers of microvascular and photoreceptor changes upon long-term evaluation in type 1 diabetes","volume":"64","author":"Fragiotta","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.oftale.2026.502655_bib0250","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/IAE.0b013e3182a10850","article-title":"Adaptive optics imaging of parafoveal cones in type 1 diabetes","volume":"34","author":"Lombardo","year":"2014","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.oftale.2026.502655_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151380","article-title":"Investigation of adaptive optics imaging biomarkers for detecting pathological changes of the cone mosaic in patients with type 1 diabetes mellitus","volume":"11","author":"Lombardo","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0260","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41598-020-57680-w","article-title":"Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices","volume":"10","author":"Parravano","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.oftale.2026.502655_bib0265","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajo.2017.04.021","article-title":"Diabetic microaneurysms internal reflectivity on spectral-domain optical coherence tomography and optical coherence tomography angiography detection","volume":"179","author":"Parravano","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502655_bib0270","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12112614","article-title":"Metabolic, microvascular, and structural predictors of long-term functional changes evaluated by multifocal electroretinogram in type 1 diabetes","volume":"12","author":"Parravano","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0275","doi-asserted-by":"crossref","first-page":"15183","DOI":"10.1038\/s41598-021-94580-z","article-title":"Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes","volume":"11","author":"Parravano","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.oftale.2026.502655_bib0280","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/bjo-2022-321617","article-title":"In vivo assessment of associations between photoreceptors structure and macular perfusion in type 1 diabetes","volume":"107","author":"Viggiano","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.oftale.2026.502655_bib0285","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00592-018-1209-9","article-title":"Early and localized retinal dysfunction in patients with type 1 diabetes mellitus studied by multifocal electroretinogram","volume":"55","author":"Ziccardi","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.oftale.2026.502655_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00417-016-3548-y","article-title":"The neurovascular unit and the pathophysiologic basis of diabetic retinopathy","volume":"255","author":"Gardner","year":"2016","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.oftale.2026.502655_bib0295","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/db18-0682","article-title":"Effects of topically administered neuroprotective drugs in early stages of diabetic retinopathy: results of the EUROCONDOR Clinical Trial","volume":"68","author":"Sim\u00f3","year":"2019","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.oftale.2026.502655_bib0300","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/aos.14912","article-title":"Topical treatment of diabetic retinopathy: a systematic review","volume":"100","author":"Thagaard","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.oftale.2026.502655_bib0305","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/db16-1453","article-title":"Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR Project","volume":"66","author":"Santos","year":"2017","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0310","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000444396","article-title":"Correlation between Retinal Vessel Calibre and Neurodegeneration in Patients with Type 2 Diabetes Mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)","volume":"56","author":"Frydkjaer-Olsen","year":"2016","journal-title":"Ophthalmic Res"},{"issue":"6","key":"10.1016\/j.oftale.2026.502655_bib0315","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1167\/iovs.18-26487","article-title":"Topical treatment with brimonidine and somatostatin causes retinal vascular dilation in patients with early diabetic retinopathy from the EUROCONDOR","volume":"60","author":"Grauslund","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.oftale.2026.502655_bib0320","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/ijms19082458","article-title":"Effects of liposomal formulation of citicoline in experimental diabetes-induced retinal neurodegeneration","volume":"19","author":"Bogdanov","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0325","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s12325-020-01284-3","article-title":"Citicoline and vitamin B12 eye drops in type 1 diabetes: results of a 3-year pilot study evaluating Morpho-functional retinal changes","volume":"37","author":"Parravano","year":"2020","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.oftale.2026.502655_bib0330","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1007\/s12325-021-01771-1","article-title":"Citicoline and vitamin B12 eye drops in type 1 diabetes: results of a 36-month pilot study evaluating macular electrophysiological changes","volume":"38","author":"Parisi","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.oftale.2026.502655_bib0335","article-title":"Citicoline in ophthalmologic practice: neuroprotection in ischemic optic neuropathy, diabetic retinopathy and amblyopia","author":"Nov\u00e2k","year":"2021","journal-title":"Arch Ukrainian Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502655_bib0340","doi-asserted-by":"crossref","DOI":"10.3390\/ph14030281","article-title":"Citicoline in ophthalmological neurodegenerative disease: a comprehensive review","volume":"14","author":"Oddone","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"10.1016\/j.oftale.2026.502655_bib0345","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/biomedicines13102358","article-title":"Citicoline may effectively reduce hard exudates in diabetic retinopathy","volume":"13","author":"Tomi\u0107","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.35479\/ijretina.2019.vol002.iss001.53","article-title":"The effect of citicoline on electroretinography abnormalities in patients with non-proliferative diabetic retinopathy","volume":"2","author":"Utami","year":"2019","journal-title":"Int J Retina"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0355","first-page":"248","article-title":"Oral citicoline and diabetic retinopathy: effects on macular ganglion cell layer thickness","volume":"13","author":"Nasrul","year":"2024","journal-title":"J Kedokteran (Unram Med J)"},{"key":"10.1016\/j.oftale.2026.502655_bib0360","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.3390\/ijms24065072","article-title":"The role of citicoline and coenzyme Q10 in retinal pathology","volume":"24","author":"Garc\u00eda-L\u00f3pez","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0365","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12902-025-01985-2","article-title":"The effects of non-insulin anti-diabetic medications on the diabetic microvascular complications: a systematic review and meta-analysis of randomized clinical trials","volume":"25","author":"Wen","year":"2025","journal-title":"BMC Endocrine Disorders"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0370","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/dom.13172","article-title":"Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy","volume":"20","author":"Vilsboll","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.oftale.2026.502655_bib0375","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.oftale.2026.502655_bib0380","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.oftale.2026.502655_bib0385","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","volume":"385","author":"Gerstein","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.oftale.2026.502655_bib0390","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12974-024-03283-5","article-title":"Sitagliptin eye drops prevent the impairment of retinal neurovascular unit in the new Trpv2(+\/-) rat model","volume":"21","author":"Ramos","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.oftale.2026.502655_bib0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208399","article-title":"Neuroprotective effects of PPAR\u03b1 in retinopathy of type 1 diabetes","volume":"14","author":"Pearsall","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.oftale.2026.502655_bib0400","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/OPTH.S236637","article-title":"The evolving treatment of diabetic retinopathy","volume":"14","author":"Mansour","year":"2020","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"7","key":"10.1016\/j.oftale.2026.502655_bib0405","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.2337\/db12-0926","article-title":"Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes","volume":"62","author":"Hernandez","year":"2013","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.oftale.2026.502655_bib0410","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.2337\/dc07-0332","article-title":"Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration","volume":"30","author":"Carrasco","year":"2007","journal-title":"Diabetes Care"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426001994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426001994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:15:09Z","timestamp":1788174909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579426001994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":82,"alternative-id":["S2173579426001994"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502655","relation":{},"ISSN":["2173-5794"],"issn-type":[{"value":"2173-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurovascular unit-targeted therapeutic strategies in diabetic retinopathy","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2026.502655","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Oftalmolog\u00eda. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502655"}}